Cardiff Oncology, Inc. (CRDF)
NASDAQ·Healthcare·Biotechnology
$1.69
-2.03%
Mkt Cap $117.59M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $103.50K | $243.00K | +134.78% | -$0.18 | -$0.11 | +38.89% | — | — |
| Q4 2025 Nov 6, 2025 | $103.50K | $120.00K | +15.94% | -$0.20 | -$0.17 | +15.00% | — | — |
| Q3 2025 Jul 29, 2025 | $109.38K | $121.00K | +10.63% | -$0.19 | -$0.21 | -10.53% | — | — |
| Q2 2025 May 8, 2025 | $89.29K | $109.00K | +22.07% | -$0.19 | -$0.20 | -5.26% | — | — |
| Q1 2025 Feb 27, 2025 | $94.17K | $151.00K | +60.35% | -$0.26 | -$0.21 | +19.23% | — | — |
| Q4 2024 Nov 7, 2024 | $70.00K | $165.00K | +135.71% | -$0.27 | -$0.25 | +7.41% | — | — |
| Q3 2024 Aug 8, 2024 | $60.00K | $163.00K | +171.67% | -$0.25 | -$0.26 | -4.00% | — | — |
| Q2 2024 May 2, 2024 | $70.00K | $205.00K | +192.86% | -$0.25 | -$0.22 | +12.00% | — | — |
| Q1 2024 Feb 29, 2024 | $40.00K | $156.00K | +290.00% | -$0.26 | -$0.21 | +19.23% | — | — |
| Q4 2023 Nov 2, 2023 | $40.00K | $141.00K | +252.50% | -$0.29 | -$0.22 | +24.14% | — | — |
| Q3 2023 Aug 9, 2023 | $40.00K | $108.00K | +170.00% | -$0.27 | -$0.25 | +7.41% | — | — |
| Q2 2023 May 4, 2023 | $60.00K | $83.00K | +38.33% | -$0.23 | -$0.25 | -8.70% | — | — |
| Q1 2023 Mar 2, 2023 | $73.25K | $128.00K | +74.74% | -$0.25 | -$0.20 | +20.00% | — | — |
| Q4 2022 Nov 3, 2022 | $68.20K | $93.00K | +36.36% | -$0.27 | -$0.20 | +25.93% | — | — |
| Q3 2022 Aug 4, 2022 | $93.00K | $91.00K | -2.15% | -$0.25 | -$0.24 | +4.00% | — | — |
| Q2 2022 May 5, 2022 | $56.60K | $74.00K | +30.74% | -$0.23 | -$0.25 | -8.70% | — | — |
| Q1 2022 Feb 24, 2022 | $41.00K | $133.00K | +224.39% | -$0.17 | -$0.23 | -35.29% | — | — |
| Q4 2021 Nov 4, 2021 | $30.00K | $86.00K | +186.67% | -$0.17 | -$0.17 | +0.00% | — | — |
| Q3 2021 Aug 5, 2021 | $150.00K | $68.00K | -54.67% | -$0.15 | -$0.17 | -13.33% | — | — |
| Q2 2021 May 6, 2021 | $150.00K | $72.00K | -52.00% | -$0.14 | -$0.14 | +0.00% | — | — |